Lentiginous melanoma: a distinctive clinicopathological entity.

Histopathology (Impact Factor: 2.86). 04/2008; 52(4):523-5. DOI: 10.1111/j.1365-2559.2008.02943.x
Source: PubMed
  • Source
    Expert Review of Dermatology 01/2008; 3(5):529-533.
  • [Show abstract] [Hide abstract]
    ABSTRACT: As the population continues to age, clinicians and dermatologists are increasingly faced with geriatric patients presenting with a range of dermatologic manifestations, including benign and malignant skin tumors. Knowledge of epidemiologic and morphologic features, including dermoscopy of common and benign melanocytic and nonmelanocytic skin tumors, provides the basis for a better understanding and management of problematic skin tumors in this age group. This article provides an overview of common and problematic skin lesions in elderly patients and addresses epidemiologic, clinical, and dermoscopic clues that aid the differential diagnosis and management of challenging skin lesions.
    Dermatologic clinics 10/2013; 31(4):549-64. · 1.29 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: On the basis of a critical review of published literature, it is concluded that there is as yet insufficient evidence to conclude that the melanocytic lesion, which is currently known as "lentiginous melanoma," is a full-fledged melanoma, with the capacity to metastasize to distant sites and to cause the demise of the patient. It is proposed that this lesion is better designated as "lentiginous SAMPUS," that is, a superficial atypical melanocytic proliferation of uncertain significance, with a lentiginous, or predominantly lentiginous, arrangement of the junctional component. As there is uncertainty regarding its actual metastatic potential or the likelihood of progression to melanoma NOS, the lesion should be removed completely, with free surgical margins.
    Advances in anatomic pathology 05/2014; 21(3):181-7. · 3.22 Impact Factor